Shatterproof Walk Returns to D.C. to Tackle Persistent Addiction Crisis

While the 446 overdose deaths recorded in 2024 mark a significant decline, the crisis remains deeply embedded in the District. Fentanyl continues to drive the majority of opioid-related fatalities, and non-fatal hospitalizations remain a persistent challenge. Beyond the statistics, the event highlights a critical treatment gap: the District currently maintains the lowest residential treatment bed capacity in the country, at just 9 beds per 100,000 residents.

Shatterproof CEO Pam Jenkins emphasizes that progress is fragile as long as families struggle to navigate a fragmented healthcare system. The event aims to mobilize public support, noting that while 90% of local residents believe insurance should cover addiction treatment, nearly half of the DMV population still incorrectly attributes substance use to a lack of moral strength. The walk serves as both a memorial for those lost and a platform for advocacy, with funds directed toward policy reform and expanding resources for those currently excluded from the recovery pipeline.